Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis (FMTUC)
Sponsor: University of Vermont
Listed as NCT02390726, this EARLY_PHASE1 trial focuses on Ulcerative Colitis, Active Moderate and remains ongoing. Sponsored by University of Vermont, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
Status: Active Not Recruiting → Unknown Status
-
Aug 2018 — Aug 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 5 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Aug 2017 — Jan 2018 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Vermont
For direct contact, visit the study record on ClinicalTrials.gov .